{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:11:38Z","timestamp":1793859098095,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejmech.2021.113313","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T02:27:32Z","timestamp":1614133652000},"page":"113313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis"],"prefix":"10.1016","volume":"216","author":[{"given":"Ran","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113313_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphar.2017.00661","article-title":"Purinergic signalling: therapeutic developments","volume":"8","author":"Burnstock","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113313_bib2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00018-007-6497-0","article-title":"Purine and pyrimidine receptors","volume":"64","author":"Burnstock","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113313_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/1568026043451014","article-title":"Introduction: P2 receptors","volume":"4","author":"Geoffrey","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113313_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pharmthera.2018.04.002","article-title":"Tools and drugs for uracil nucleotide-activated P2Y receptors","volume":"190","author":"Rafehi","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113313_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/mol.115.098756","article-title":"UDP-Sugars as extracellular signaling molecules: cellular and physiologic consequences of P2Y14 receptor activation","volume":"88","author":"Lazarowski","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113313_bib6","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1074\/jbc.275.15.10767","article-title":"A\u00a0G protein-coupled receptor for UDP-glucose","volume":"275","author":"Chambers","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113313_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/mol.113.085654","article-title":"A\u00a0selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils","volume":"84","author":"Barrett","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113313_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10571-012-9869-4","article-title":"Secretion of matrix metalloproteinase-9 from astrocytes by inhibition of tonic P2Y(14)-receptor-mediated signal(s)","volume":"33","author":"Kinoshita","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113313_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bcp.2009.10.024","article-title":"UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation","volume":"79","author":"Gao","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113313_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pupt.2017.05.005","article-title":"Lipopolysaccharide (LPS) induced pulmonary neutrophil recruitment and platelet activation is mediated via the P2Y1 and P2Y14 receptors in mice","volume":"45","author":"Amison","year":"2017","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113313_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s11302-016-9524-5","article-title":"UDP-glucose promotes neutrophil recruitment in the lung","volume":"12","author":"Sesma","year":"2016","journal-title":"Purinergic Signal."},{"issue":"34","key":"10.1016\/j.ejmech.2021.113313_bib12","doi-asserted-by":"crossref","first-page":"23353","DOI":"10.1074\/jbc.M114.580803","article-title":"The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice","volume":"289","author":"Meister","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113313_bib13","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.4049\/jimmunol.1103207","article-title":"GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity","volume":"189","author":"Xu","year":"2012","journal-title":"J.\u00a0Immunol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113313_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121419","article-title":"Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor","volume":"10","author":"Azroyan","year":"2015","journal-title":"PloS One"},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2021.113313_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0169-328X(03)00330-9","article-title":"GPR105, a novel Gi\/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function","volume":"118","author":"Moore","year":"2003","journal-title":"Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113313_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113313_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jid.2016.01.026","article-title":"Monosodium urate crystals induce functional expression of P2Y14 receptor in human keratinocytes","volume":"136","author":"Uratsuji","year":"2016","journal-title":"J.\u00a0Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113313_bib18","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1172\/JCI134791","article-title":"Pro-inflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice","volume":"130","author":"Battistone","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113313_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41419-020-2609-7","article-title":"P2Y(14) receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113313_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2019.04.068","article-title":"Recent progress on the discovery of P2Y14 receptor antagonists","volume":"175","author":"Lu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113313_bib21","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.bmcl.2011.03.084","article-title":"Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists","volume":"21","author":"Guay","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113313_bib22","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.bmcl.2011.03.081","article-title":"The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14","volume":"21","author":"Gauthier","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"14","key":"10.1016\/j.ejmech.2021.113313_bib23","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1016\/j.bmcl.2010.12.113","article-title":"Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y(14)","volume":"21","author":"Robichaud","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"17","key":"10.1016\/j.ejmech.2021.113313_bib24","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1021\/acs.jmedchem.0c00745","article-title":"Exploration of alternative scaffolds for P2Y14 receptor antagonists containing a biaryl core","volume":"63","author":"Jung","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113313_bib25","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/cb500614p","article-title":"Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probes","volume":"9","author":"Kiselev","year":"2014","journal-title":"ACS Chem. Biol."},{"issue":"13","key":"10.1016\/j.ejmech.2021.113313_bib26","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1021\/acs.jmedchem.6b00044","article-title":"Structure-based design of 3-(4-aryl-1H-1,2,3-triazol-1-yl)-Biphenyl derivatives as P2Y14 receptor antagonists","volume":"59","author":"Junker","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113313_bib27","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1021\/acs.jmedchem.8b00168","article-title":"Structure-guided modification of heterocyclic antagonists of the P2Y14 receptor","volume":"61","author":"Yu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113313_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phymed.2018.03.007","article-title":"4-(2-(4-chlorophenyl)-1- ((4-chlorophenyl)amino)ethyl)benzene-1,3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3","volume":"42","author":"Zhou","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2021.113313_bib29","doi-asserted-by":"crossref","first-page":"111564","DOI":"10.1016\/j.ejmech.2019.111564","article-title":"Design, synthesis and anti-inflammatory evaluation of 3-amide-benzoic acid derivatives as novel P2Y14 receptor antagonists","volume":"181","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:24:17Z","timestamp":1759328657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":29,"alternative-id":["S0223523421001628"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113313","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113313"}}